Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
21,794.00
19,059.20
16,612.50
14,662.64
10,560.01
11,246.80
9,617.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
21,794.00
19,059.20
16,612.50
14,662.64
10,560.01
11,246.80
9,617.44
Raw Material Cost
2,754.40
2,454.10
2,283.80
2,685.48
1,623.31
1,809.23
1,644.88
Purchase of Finished goods
8,556.70
7,384.90
6,315.00
4,961.33
4,186.06
3,796.67
3,087.55
(Increase) / Decrease In Stocks
-1.10
-33.50
-24.50
-73.34
-125.17
-107.03
-71.56
Employee Cost
2,769.20
2,493.70
2,176.70
1,786.52
1,600.97
1,852.92
1,598.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
4,693.00
4,369.30
3,811.90
3,117.53
2,137.43
2,307.72
2,294.67
Total Expenditure (Excl Depreciation)
18,772.20
16,668.50
14,562.90
12,477.52
9,422.60
9,659.51
8,553.78
Operating Profit (PBDIT) excl Other Income
3,021.80
2,390.70
2,049.60
2,185.12
1,137.41
1,587.29
1,063.66
Other Income
200.30
106.30
90.30
78.14
44.99
26.97
31.44
Operating Profit (PBDIT)
3,222.10
2,497.00
2,139.90
2,263.26
1,182.40
1,614.26
1,095.10
Interest
458.50
449.40
380.80
378.64
449.22
532.77
327.02
Exceptional Items
0.00
1.90
0.00
294.11
60.65
198.30
0.00
Gross Profit (PBDT)
2,763.60
2,049.50
1,759.10
2,178.73
793.83
1,279.79
768.08
Depreciation
757.50
687.00
615.40
600.70
573.13
619.69
395.53
Profit Before Tax
2,006.10
1,362.50
1,143.70
1,578.03
220.70
660.10
372.55
Tax
534.00
445.50
256.20
477.02
84.70
225.19
173.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,472.10
917.00
887.50
1,101.01
136.00
434.91
199.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,472.10
917.00
887.50
1,101.01
136.00
434.91
199.18
Share in Profit of Associates
33.00
18.00
-43.20
7.35
0.77
-3.11
0.98
Minority Interest
-59.20
-36.40
-25.20
-52.75
13.59
23.14
35.88
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,445.90
898.60
819.10
1,055.61
150.36
454.94
236.04
Equity Capital
71.90
71.90
71.89
71.89
71.89
69.56
69.56
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
8,132.60
6,855.70
6,117.49
5,543.45
4,522.93
3,262.09
3,256.11
Earnings per share (EPS)
100.55
62.49
56.97
73.42
10.46
32.7
16.97
Diluted Earnings per share
100.56
62.5
56.97
73.42
10.74
32.7
16.97
Operating Profit Margin (Excl OI)
13.87%
12.54%
12.34%
14.9%
10.77%
14.11%
11.06%
Gross Profit Margin
12.68%
10.75%
10.59%
14.86%
7.52%
11.38%
7.99%
PAT Margin
6.91%
4.91%
5.08%
7.56%
1.3%
3.84%
2.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.35% vs 14.73% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 60.91% vs 9.71% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 26.40% vs 16.64% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 2.02% vs 18.01% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Apollo Hospitals With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
21,794.00
7,028.46
14,765.54
210.08%
Other Operating Income
0.00
0.00
0.00
Total Operating income
21,794.00
7,028.46
14,765.54
210.08%
Raw Material Cost
2,754.40
1,496.41
1,257.99
84.07%
Purchase of Finished goods
8,556.70
0.00
8,556.70
(Increase) / Decrease In Stocks
-1.10
-19.36
18.26
94.32%
Employee Cost
2,769.20
1,174.01
1,595.19
135.88%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
1,474.70
-1,474.70
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4,693.00
1,053.90
3,639.10
345.30%
Total Expenditure (Excl Depreciation)
18,772.20
5,179.66
13,592.54
262.42%
Operating Profit (PBDIT) excl Other Income
3,021.80
1,848.80
1,173.00
63.45%
Other Income
200.30
155.64
44.66
28.69%
Operating Profit (PBDIT)
3,222.10
2,004.44
1,217.66
60.75%
Interest
458.50
165.02
293.48
177.85%
Exceptional Items
0.00
-73.63
73.63
100.00%
Gross Profit (PBDT)
2,763.60
1,765.79
997.81
56.51%
Depreciation
757.50
359.42
398.08
110.76%
Profit Before Tax
2,006.10
1,406.37
599.73
42.64%
Tax
534.00
330.49
203.51
61.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,472.10
1,075.88
396.22
36.83%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,472.10
1,075.88
396.22
36.83%
Share in Profit of Associates
33.00
0.00
33.00
Minority Interest
-59.20
0.00
-59.20
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,445.90
1,075.88
370.02
34.39%
Equity Capital
71.90
972.14
-900.24
-92.60%
Face Value
5.00
10.00
0.00
Reserves
8,132.60
8,408.73
-276.13
-3.28%
Earnings per share (EPS)
100.55
11.07
89.48
808.31%
Diluted Earnings per share
100.56
11.01
89.55
813.35%
Operating Profit Margin (Excl OI)
13.87%
26.30%
0.00
-12.43%
Gross Profit Margin
12.68%
25.12%
0.00
-12.44%
PAT Margin
6.91%
15.31%
0.00
-8.40%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 21,794.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.35% vs 14.73% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1,445.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 60.91% vs 9.71% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,021.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.40% vs 16.64% in Mar 2024
Annual - Interest
Interest 458.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.02% vs 18.01% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.87%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






